Zobrazeno 1 - 10 of 172 pro vyhledávání: '"Emmanuel E, Zervos"'
1
Akademický článek
Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter
Autor: Timothy L. Fitzgerald, Catalina Mosquera, Nicholas J. Koutlas, Nasreen A. Vohra, Kimberly V. Edwards, Emmanuel E. Zervos
Publikováno v: Surgery Research and Practice, Vol 2016 (2016)
Benefits of ERAS protocol have been well documented; however, it is unclear whether the improvement stems from the protocol or shifts in expectations. Interdisciplinary educational seminars were conducted for all health professionals. However, one te
Externí odkaz: https://doaj.org/article/66f6e9eb58e04a56aaf7b73a5e4d37e6
Zobrazit plný text záznamu
2
When Is It Safe to Proceed With Pancreaticoduodenectomy Without Biliary Decompression?
Autor: Catalina Mosquera, Emmanuel E. Zervos, Timothy L. Fitzgerald, Anastasios Mitsakos, Rodney L. Guyton
Publikováno v: The American Surgeon. 87:825-832
Background An absolute bilirubin level where preoperative biliary decompression (PBD) is indicated before pancreaticoduodenectomy has been elusive. Our goal was to identify a total bilirubin level whereby biliary decompression provides clear benefit,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3c7f7e80f354965e1146f2b4027a1d
https://doi.org/10.1177/0003134820971618
Zobrazit plný text záznamu
5
Improvement in Surgical Quality Following Pancreaticoduodenectomy With Increasing Case Volume in a Rural Hospital
Autor: Nasreen A. Vohra, Alexander A. Parikh, Rebecca A. Snyder, Peter G. Buccini, Emmanuel E. Zervos, Timothy L. Fitzgerald, Anastasios Mitsakos
Publikováno v: The American surgeon. 88(4)
Background The literature is replete with studies that define the nexus of quantity and quality in complex surgical operations. These observations have heralded a call for centralization of care to high-volume centers. The purpose of this study was t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7970f66d16c05824015757ca51d5d2b
https://pubmed.ncbi.nlm.nih.gov/34792413
Zobrazit plný text záznamu
6
Predictive Value of Preoperative Serum CA19-9 on Margin Status
Autor: Catalina Mosquera, Shachar Laks, William Irish, Helen M. Johnson, Emmanuel E. Zervos, Nelly Bellamy, Anastasios Mitsakos, Nina E Neill
Publikováno v: The American Surgeon. 85:965-972
Serum carbohydrate antigen (CA19-9) is known to correlate with stage, resectability, and prognosis of pancreatic cancer. The goal of pancreaticoduodenectomy is to achieve an R0 resection because worse outcomes are reported in the presence of positive
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::997acc3681607ef446c86d138e1e7917
https://doi.org/10.1177/000313481908500937
Zobrazit plný text záznamu
8
Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis
Autor: Scarlett Hao, Janet E. Tuttle-Newhall, Rebecca A. Snyder, Alexander A. Parikh, William Irish, Emmanuel E. Zervos
Publikováno v: Journal of the American College of Surgeons. 230(4)
Approximately 20% of patients with colorectal cancer (CRC) present with synchronous liver metastases (CRLM). The decision to resect simultaneously or sequentially remains controversial. The primary aim of this study was to determine whether simultane
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e6dcab58118d1cad1941f0a2a093002
https://pubmed.ncbi.nlm.nih.gov/32220454
Zobrazit plný text záznamu
9
Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials
Autor: Catalina Mosquera, Dino Maglic, Emmanuel E. Zervos
Publikováno v: Cancer Genetics. 209:567-581
Molecular targeted therapy is widely utilized and effective in a number of solid tumors. In pancreatic adenocarcinoma, targeted therapy has been extensively evaluated; however, survival improvement of this aggressive disease using a targeted strategy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad0b7d39c2605729c41ec691dcb7083
https://doi.org/10.1016/j.cancergen.2016.07.003
Zobrazit plný text záznamu
10
Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX
Autor: Shahriar Sharif, Antonio Ucar, Ramtin Agah, Reza Nazemzadeh, Charles Charles Li, Ki Y. Chung, Pashtoon Murtaza Kasi, Wesley B. Jones, Hassan Hatoum, Jochen Decaestecker, Thierry Delaunoit, Paula M. Novelli, Charles D. Lopez, Kenneth L Meredith, Michael J. Pishvaian, Emmanuel E. Zervos, Amer H. Zureikat, Adel Kardosh, Erik Vandestraeten, Ripal T. Gandhi
Publikováno v: Journal of Clinical Oncology. 39:381-381
381 Background: There is no established treatment for locally advanced pancreatic cancer (LAPC), but by utilizing the regimens approved for metastatic pancreatic cancer, hope remains for rendering tumors resectable with chemotherapy. In this context,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c05768f07cd5328c7db832d5a345f47
https://doi.org/10.1200/jco.2021.39.3_suppl.381
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje